These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Morelli S; Ferri C J Rheumatol; 1996 Apr; 23(4):789-91. PubMed ID: 8730152 [No Abstract] [Full Text] [Related]
31. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Cottin V; Fabien N; Khouatra C; Moreira A; Cordier JF Eur Respir J; 2009 Jan; 33(1):219-21. PubMed ID: 19118235 [No Abstract] [Full Text] [Related]
32. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962 [TBL] [Abstract][Full Text] [Related]
33. [Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux]. Sosnovskaya AV; Fomin VV; Popova EN; Lebedeva MV; Moiseev SV; Svistunov AA; Mukhin NA Ter Arkh; 2015; 87(3):42-47. PubMed ID: 26027239 [TBL] [Abstract][Full Text] [Related]
34. The correlation between pulmonary fibrosis and methylation of peripheral Smad3 in cases of pigeon breeder's lung in a Chinese Uygur population. Wu C; Ding W; Li Q; Wang W; Deng M; Jin R; Pang B; Yang X Oncotarget; 2017 Jun; 8(26):43104-43113. PubMed ID: 28562330 [TBL] [Abstract][Full Text] [Related]
35. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Takahashi H; Shiratori M; Kanai A; Chiba H; Kuroki Y; Abe S Respirology; 2006 Jan; 11 Suppl():S51-4. PubMed ID: 16423272 [TBL] [Abstract][Full Text] [Related]
37. [Determination of blood procollagen III peptide as an early indicator of pulmonary fibrosis in exposure to asbestos]. Cavalleri A; Gobba FM; Ferrari D; Bacchella L; Candela S; Magnani N Med Lav; 1988; 79(5):351-62. PubMed ID: 3252126 [No Abstract] [Full Text] [Related]
38. Pulmonary fibrosis. Analysis of data on 46 cases. Baldi S; Scappaticci E; Rapellino M; Obert R; Coni F; Libertucci D; Oliaro A; Cannizzo S Panminerva Med; 1987; 29(3):207-10. PubMed ID: 2827092 [No Abstract] [Full Text] [Related]
39. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis. Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758 [TBL] [Abstract][Full Text] [Related]
40. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Gordon MM; Madhok R J Rheumatol; 1996 Apr; 23(4):788-9. PubMed ID: 8730151 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]